DIN 02456419 — CINQAIR 10 MG
CINQAIR is a solution of Reslizumab marketed by TEVA CANADA LIMITED. The full Reslizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456419
- Brand name
- CINQAIR
- Active ingredient
- Reslizumab
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Interleukin-5 (IL-5) inhibitor (anti-IL-5 monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.